1900 M Street, NW 3rd Floor
Washington, DC 20036
If it passes in Congress, the unfortunately named Hatch-Waxman Integrity Act of 2018 would ultimately delay generic drug competition and increase drug prices.
California Health Care Foundation (CHCF) interviews Waxman Strategies Chairman Henry Waxman on the changing political landscape of health care reform.
Are you innovating? Interested in creating real and lasting change? See how Waxman can help.
Get In Touch